Stoke Therapeutics, Inc.

STOK · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$83,394$101,472$274,817$127,983
Short-Term Investments$164,916$146,236$82,507$88,916
Receivables$10,837$1,622$606$700
Inventory$0$0$0$0
Other Curr. Assets$5,543$6,946$5,112$4,040
Total Curr. Assets$272,437$269,970$375,736$232,756
Property Plant & Equip (Net)$6,791$6,561$7,442$8,254
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$80,315$107,256$22,989$29,824
Tax Assets$0$0$0$0
Other NC Assets$721$721$721$721
Total NC Assets$87,827$114,538$31,152$38,799
Other Assets$0$0$0$0
Total Assets$360,264$384,508$406,888$271,555
Liabilities
Payables$5,871$4,313$2,186$2,498
Short-Term Debt$0$0$0$0
Tax Payable$0$0$0$0
Deferred Revenue$5,763$8,749$18,164$18,991
Other Curr. Liab.$8,017$6,865$5,012$8,439
Total Curr. Liab.$41,727$38,678$44,685$40,056
LT Debt$0$0$0$0
Deferred Rev, NC$8,558$9,632$10,255$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$1,874$1,255$1,874$2,478
Total NC Liab.$10,432$10,887$12,129$2,478
Other Liabilities$0$0$0$0
Cap. Leases$0$2,296$2,351$2,322
Total Liabilities$52,159$49,565$56,814$42,534
Equity
Pref Stock$0$0$0$0
Common Stock$5$5$5$5
Retained Earnings-$439,781-$401,434-$377,951-$490,830
AOCI$446$96-$104-$151
Other Equity$0$0$0$0
Total Equity$308,105$334,943$350,074$229,021
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$360,264$384,508$406,888$271,555
Net Debt-$83,394-$101,472-$274,817-$127,983